RankingsPricing
  1. US-listed companies
  2. Edwards Lifesciences Corp
  3. Financials
  4. Gross profit

Edwards Lifesciences CorpEW

Market cap
$49.9B
P/E ratio
SummaryFinancials
Period EndGross profit (Million USD)YoY (%)
Dec 31, 20244,322-6.55%
Dec 31, 20234,625+7.51%
Dec 31, 20224,302+7.99%
Dec 31, 20213,984+20.51%
Dec 31, 20203,306+2.23%
Dec 31, 20193,234+16.17%
Dec 31, 20182,783+8.73%
Dec 31, 20172,560+18.17%
Dec 31, 20162,166+15.44%
Dec 31, 20151,877+10.56%
Dec 31, 20141,697+11.44%
Dec 31, 20131,523+8.41%
Dec 31, 20121,405+18.19%
Dec 31, 20111,189+14.45%
Dec 31, 20101,039

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)